Dermatop and Subileus - a phase IV clinical study of FDA data

Summary:

Subileus is reported as a side effect among people who take Dermatop (prednicarbate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Clexane, and have Cerebrovascular disorder.

The phase IV clinical study analyzes which people have Subileus when taking Dermatop. It is created by eHealthMe based on reports of 354 people who have side effects when taking Dermatop from the FDA, and is updated regularly.

What is Dermatop?

Dermatop has active ingredients of prednicarbate. eHealthMe is studying from 356 Dermatop users. Check the latest studies of Dermatop.

What is Subileus?

Subileus is found to be associated with 276 drugs and 515 conditions by eHealthMe. Check the latest studies of Subileus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

354 people reported to have side effects when taking Dermatop.
Among them, 12 people (3.39%) have Subileus.

Among these 12 people:

How long have people been on Dermatop when they have Subileus? *

What is the gender of people who have Subileus when taking Dermatop? *

female: 0.0 %
male: 100 %

What is the age of people who have Subileus when taking Dermatop? *

What are other drugs people take besides Dermatop? *

Clexane: 12 people, 100.00%
Mcp: 9 people, 75.00%

What are other side effects people have besides Subileus? *

Wound Infection: 12 people, 100.00%
Wound Haemorrhage (bleeding wound): 12 people, 100.00%
Proctalgia (pain in the rectum): 12 people, 100.00%
High Blood Pressure: 12 people, 100.00%
Haemorrhage (bleeding): 12 people, 100.00%
Haemoglobin Decreased: 12 people, 100.00%
Fever: 12 people, 100.00%
Faecaloma (hard mass of fecal matter): 12 people, 100.00%
Delirium (wild excitement): 12 people, 100.00%
Ascites (accumulation of fluid in the abdominal cavity): 12 people, 100.00%

What are the existing conditions these people have? *

Urinary Tract Infection: 12 people, 100.00%
Thrombosis (formation of a blood clot inside a blood vessel): 12 people, 100.00%
Rashes (redness): 12 people, 100.00%
Nausea (feeling of having an urge to vomit): 12 people, 100.00%
High Blood Pressure: 12 people, 100.00%
Diarrhea: 12 people, 100.00%
Colon Cancer: 12 people, 100.00%
Cerebrovascular Disorder (disease of brain): 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Dermatop and have Subileus?

- Check whether Subileus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dermatop:

Dermatop (356 reports)

Subileus treatments and more:

Subileus (2,926 reports)

Browse all side effects of Dermatop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subileus:

Subileus (276 drugs)

Browse all the conditions that are associated with Subileus:

Subileus (515 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednicarbate (the active ingredients of Dermatop) and Dermatop (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.